Bv8/PK-2 inhibitor

prokineticin-2 (PK-2) pathway inhibitor

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bv8/PK-2 inhibitor, covering 2013-11-21 to 2013-11-21. Get the full timeline:

Most recent: Clinical Trial Update: Tissue Study of Bv8/PK-2 Inhibition in Human Cancer